1 |
左金华. 原发性脑干损伤患者的观察与刺激性护理[J].中国保健营养,2021,31(16):178,182.
|
|
ZUO J H. Observation and stimulating nursing care of patients with primary brain stem injury[J]. Zhongguo Baojian Yingyang,2021,31(16):178,182.
|
2 |
SUN R, YANG S, ZHOU Z. Pathological and immunohistochemical study of lethal primary brain stem injuries[J]. Diagn Pathol,2012,7:54. doi:10.1186/1746-1596-7-54 .
|
3 |
向青青,李志刚. 原发性脑干损伤致死1例[J].广东公安科技,2022,30(2):70-71.
|
|
XIANG Q Q, LI Z G. Death due to primary brain stem injury: A case report[J]. Guangdong Gongan Keji,2022,30(2):70-71.
|
4 |
姚青松,宋一璇,黄正光,等. 原发性脑干损伤组织学诊断要点[J].中国法医学杂志,2004,19(3):134-137. doi:10.13618/j.issn.1001-5728.2004.03.002 .
|
|
YAO Q S, SONG Y X, HUANG Z G, et al. Pathognostic findings of primary injuries on the brain stem[J]. Zhongguo Fayixue Zazhi,2004,19(3):134-137.
|
5 |
SHUKLA D, MAHADEVAN A, SASTRY K V R, et al. Pathology of post traumatic brainstem and hypothalamic injuries[J]. Clin Neuropathol,2007,26(9):197-209. doi:10.5414/npp26197 .
|
6 |
冯伟臣. 原发性脑干损伤死亡法医学鉴定中应注意的几个问题[C]//法医临床学专业理论与实践——中国法医学会·全国第二十届法医临床学学术研讨会论文集.乌鲁木齐,2017:26-27.
|
|
FENG W C. Several problems should be paid attention to the forensic medical identification of death from primary brain stem injury[C]// Theory and Practice of Forensic Clinical Science — Chinese Forensic Medicine Association · Proceedings of the 20th Forensic Clinical Medicine Symposium. Urumqi,2017:26-27.
|
7 |
谷祯,牛佳佳,安国帅,等. 代谢组学在心脏性猝死鉴定中的应用前景及展望[J].法医学杂志,2021,37(3):388-395. doi:10.12116/j.issn.1004-5619.2019.491116 .
|
|
GU Z, NIU J J, AN G S, et al. Application prospects and prospect of metabolomics in the identification of sudden cardiac death[J]. Fayixue Zazhi,2021,37(3):388-395.
|
8 |
SZEREMETA M, PIETROWSKA K, NIEMCUNO-WICZ-JANICA A, et al. Applications of metabolomics in forensic toxicology and forensic medicine[J]. Int J Mol Sci,2021,22(6):3010. doi:10.3390/ijms22063010 .
|
9 |
DAWIDOWSKA J, KRZYŻANOWSKA M, MAR-KUSZEWSKI M J, et al. The application of metabolomics in forensic science with focus on forensic toxicology and time-of-death estimation[J]. Metabolites,2021,11(12):801. doi:10.3390/metabo11120801 .
|
10 |
MYCHASIUK R, FARRAN A, ANGOA-PEREZ M, et al. A novel model of mild traumatic brain injury for juvenile rats[J]. J Vis Exp,2014(94):51820. doi:10.3791/51820 .
|
11 |
TRIBA M N, LE MOYEC L, AMATHIEU R, et al. PLS/OPLS models in metabolomics: The impact of permutation of dataset rows on the K-fold cross-validation quality parameters[J]. Mol Biosyst,2015,11(1):13-19. doi:10.1039/c4mb00414k .
|
12 |
马占君,李振国,王欢,等. 基于液相色谱-串联质谱的结肠癌血清氧固醇标志物筛选[J].色谱,2022,40(6):541-546. doi:10.3724/SP.J.1123.2022.01001 .
|
|
MA Z J, LI Z G, WANG H, et al. Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry[J]. Sepu,2022,40(6):541-546.
|
13 |
TALLENT W H. Two new antibiotic cyclopentanoid monoterpenes of plant origin[J]. Tetrahedron,1964,20(7):1781-1787. doi:10.1016/S0040-4020(01)99179-3 .
|
14 |
付庆,单淇,周钰通,等. 栀子中环烯醚萜类成分抗阿尔茨海默病的作用机制研究进展[J].中国药房,2022,33(1):123-128. doi:10.6039/j.issn.1001-0408.2022.01.21 .
|
|
FU Q, SHAN Q, ZHOU Y T, et al. Research progress on the mechanism of iridoids from Gardenia jasminoides against Alzheimer’s disease[J]. Zhongguo Yaofang,2022,33(1):123-128.
|
15 |
NAM K N, CHOI Y S, JUNG H J, et al. Genipin inhibits the inflammatory response of rat brain microglial cells[J]. Int Immunopharmacol,2010,10(4):493-499. doi:10.1016/j.intimp.2010.01.011 .
|
16 |
CHEN M K, PENG C C, MANER R S, et al. Geniposide ameliorated fluoxetine-suppressed neurite outgrowth in Neuro2a neuroblastoma cells[J]. Life Sci,2019,226:1-11. doi:10.1016/j.lfs.2019.04.003 .
|
17 |
张志华. 京尼平苷对APP/PS1小鼠行为学损伤和病理变化的保护作用及分子机制——抑制mTOR信号通路增强自噬的研究[D].太原:山西医科大学,2019.
|
|
ZHANG Z H. Protective effects of geniposide on behavioral and pathologic changes in APP/PS1 mice and exploration of molecular mechanism: Down regulation of mTOR signal pathway and enhancement of autophagy[D]. Taiyuan: Shanxi Medical University,2019.
|
18 |
张青,李梦婷,李梅,等. 杜仲提取物多次给药后在正常大鼠和SHR模型体内的药动学比较研究[J].中国比较医学杂志,2022,32(1):41-47. doi:10.3969/j.issn.1671-7856.2022.01.005 .
|
|
ZHANG Q, LI M T, LI M, et al. Pharmacokinetic comparison of active components in an Eucommia ulmoides extract by multiple administrations between normal and spontaneously hypertensive rats[J]. Zhongguo Bijiao Yixue Zazhi,2022,32(1):41-47.
|
19 |
BEYOĞLU D, IDLE J R. Metabolomic and lipidomic biomarkers for premalignant liver disease diagnosis and therapy[J]. Metabolites,2020,10(2):50. doi:10.3390/metabo10020050 .
|
20 |
RYOU M, STYLOPOULOS N. Endoscopic ultra-sound-guided sampling and profiling of portal circulation in human patients for metabolic research studies and biomarker assessment[J]. Am J Physiol Gastrointest Liver Physiol,2020,319(5):G584-G588. doi:10.1152/ajpgi.00135.2020 .
|
21 |
KURNIK-ŁUCKA M, PANULA P, BUGAJSKI A, et al. Salsolinol: An unintelligible and double-faced molecule — Lessons learned from in vivo and in vitro experiments[J]. Neurotox Res,2018,33(2):485-514. doi:10.1007/s12640-017-9818-6 .
|
22 |
张芳芳,李梓晗,高怿宣,等. 基于转录组测序技术揭示salsolinol的神经毒性作用[J].生命科学仪器,2021,19(6):29-34. doi:10.11967/2021191204 .
|
|
ZHANG F F, LI Z H, GAO Y X, et al. Neurotoxic effects of salsolinol revealing by transcriptome analysis[J]. Shengming Kexue Yiqi,2021,19(6):29-34.
|
23 |
MURAI Y, SEKIGUCHI A, HIRAKAWA T, et al. Evaluation of chiral N, N-dimethyl-sphingosine for the interaction between nerve growth factor and tropomyosin receptor kinase A[J]. Chirality,2022,34(5):807-812. doi:10.1002/chir.23433 .
|